Janus Henderson Group
CNTB

Janus Henderson Group’s Connect Biopharma Holdings CNTB Stock Holding History

Janus Henderson Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-720,000
Closed -$637K – 2552
2022
Q2 		$637K Sell
720,000
-879,826
-55% -$1.3M ﹤0.01% 1604
2022
Q1 		$4.81M Buy
1,599,826
+1,173,974
+276% +$4.96M ﹤0.01% 1022
2021
Q4 		$2.2M Buy
425,852
+22,393
+6% +$249K ﹤0.01% 1242
2021
Q3 		$9.57M Buy
403,459
+12,120
+3% +$274K ﹤0.01% 918
2021
Q2 		$7.6M Sell
391,339
-83,661
-18% -$1.4M ﹤0.01% 981
2021
Q1 		$8.7M Buy
+475,000
New +$8.08M ﹤0.01% 912

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group's CNTB Position: Q3 2022 in Review

Janus Henderson Group sold out of Connect Biopharma Holdings (CNTB) in Q3 2022, closing a stake of 720,000 shares — an estimated $637K sold.

Janus Henderson Group first reported a position in CNTB in Q1 2021 and held it in 6 quarters. The position peaked at $9.57M in Q3 2021. 25 funds tracked by Wall St. Rank hold CNTB as of Q3 2022.

  • Janus Henderson Group reported no remaining Connect Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • Janus Henderson Group sold 720,000 Connect Biopharma Holdings shares in Q3 2022, an estimated $637K.
  • Janus Henderson Group first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 6 quarters.
  • Janus Henderson Group's Connect Biopharma Holdings position peaked at $9.57M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2022.

Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.